Clinical and pharmacological group: & nbsp

Antiparasitic agents

Included in the formulation
  • Spregal
    aerosol externally 
  • АТХ:

    P.03.A.X   Other preparations for the destruction of ectoparasites

    Pharmacodynamics:

    Combined drug.

    Esbiol disrupts the cation exchange of membranes of insect nerve cells.

    Piperonyl butoxide enhances the effects of esbiol.

    Pharmacokinetics:

    The drug for topical application does not have a systemic effect on the body.

    Indications:

    It is used to treat scabies.

    I.B85-B89.B86   Scabies

    Contraindications:

    Bronchial asthma, obstructive bronchitis, individual intolerance.

    Carefully:

    Pregnancy and lactation.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. In pregnancy and lactation, use with caution, in cases where the expected effect exceeds the risk to the fetus and newborn.

    Dosing and Administration:

    Locally, as an aerosol, once.

    Side effects:

    Allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    The procedures are carried out in well-ventilated areas. For preventive purposes, treatment of bed and clothes is recommended.

    Instructions
    Up